This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cedars-Sinai Medical Center. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Anjali Jain: Innovator in Cancer Treatment
Introduction
Anjali Jain is a prominent inventor based in Los Angeles, CA, who has made significant contributions to the field of cancer treatment. With a focus on innovative methods to combat prostate cancer, her work is paving the way for new therapeutic approaches.
Latest Patents
Anjali Jain holds a patent for her invention titled "Targeting microRNA miR-409-3P to treat prostate cancer." This patent describes methods of treating cancer, cancer metastasis, and drug-resistant cancers using miRNA inhibitors. Specifically, it highlights the use of inhibitors of miR-409-5p, miR-409-3p, and miR-154. Additionally, the invention outlines methods for using miRNA as biomarkers to predict responsiveness to cancer drugs and to detect disease states of cancer. Anjali Jain has 1 patent to her name.
Career Highlights
Anjali Jain is affiliated with Cedars-Sinai Medical Center, where she continues her research and development in cancer therapies. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Anjali collaborates with esteemed colleagues, including Sajni Josson and Murali Gururajan, who contribute to her research efforts and enhance the impact of her innovations.
Conclusion
Anjali Jain's innovative work in targeting microRNA for cancer treatment exemplifies her dedication to advancing medical research. Her contributions are vital in the ongoing fight against cancer, and her patent reflects her commitment to improving therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile